SCHEMBL27744022

SCHEMBL27744022

C=CC(c1cccnc1)S(=O)(=O)n1cc(CN(C)C(=O)OC(C)(C)C)cc1-c1ccccc1CO

nearest known ligand 0.33

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
▸ KCNA5 P22460 1/20 0.33
▸ HTR2C P28335 2/20 0.32
▸ SLC6A4 P31645 2/20 0.32
▸ RIPK1 Q13546 1/20 0.31
▸ NAMPT P43490 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ CYP3A5 P20815 1/20 0.30
▸ NPSR1 Q6W5P4 1/20 0.30
▸ LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1278573 0.83 NAMPT (0.35) HTR2CSLC6A4RIPK1NAMPT
SCHEMBL27744000 0.81 KCNA5 (0.30) KCNA5
SCHEMBL27744020 0.80 NAMPT (0.37) HTR2CSLC6A4RIPK1NAMPT
SCHEMBL27743985 0.79 HTR2C (0.35) HTR2CSLC6A4NPSR1
SCHEMBL4793917 0.79 HTR2C (0.32) HTR2CSLC6A4RIPK1NAMPT
SCHEMBL27723214 0.77 HTR2C (0.36) HTR2CSLC6A4NPSR1
SCHEMBL28772918 0.76 CYP3A4 (0.36) NAMPTCYP3A4NPSR1LMNA
SCHEMBL1278709 0.75 PTGER2 (0.33) HTR2CSLC6A4RIPK1NAMPT
SCHEMBL1157020 0.74 TACR1 (0.41) HTR2CSLC6A4RIPK1NAMPTNPSR1
SCHEMBL27743996 0.73 AKT1 (0.37) NAMPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101300229-B 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors TAKEDA PHARMACEUTICAL 2011-10-05 — — CN disclosed
CN-101300229-A 1-heterocyclylsulfonyl, 2-aminomethyl, 5- (hetero-) aryl substituted 1-h-pyrrole derivatives as acid secretion inhibitors TAKEDA PHARMACEUTICAL (JP) 2008-11-05 — — CN disclosed
Send feedback